{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 56908
    }
  },
  "results": [
    {
      "safetyreportversion": "2",
      "safetyreportid": "10003627",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "1",
      "serious": "1",
      "seriousnessother": "1",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20140312",
      "fulfillexpeditecriteria": "1",
      "companynumb": "US-GE HEALTHCARE MEDICAL DIAGNOSTICS-OSCN-PR-0806S-0355",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "GE HEALTHCARE",
        "duplicatenumb": "US-GE HEALTHCARE MEDICAL DIAGNOSTICS-OSCN-PR-0806S-0355"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "4"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "38",
        "patientonsetageunit": "801",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Nephrogenic systemic fibrosis",
            "reactionoutcome": "3"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "OMNISCAN",
            "drugauthorizationnumb": "020123",
            "drugdosageform": "SOLUTION FOR INJECTION",
            "drugadministrationroute": "042",
            "drugindication": "RENAL FAILURE CHRONIC",
            "drugstartdateformat": "102",
            "drugstartdate": "20020215",
            "drugenddateformat": "102",
            "drugenddate": "20020215",
            "openfda": {
              "application_number": [
                "NDA020123"
              ],
              "brand_name": [
                "OMNISCAN"
              ],
              "generic_name": [
                "GADODIAMIDE"
              ],
              "manufacturer_name": [
                "GE Healthcare Inc."
              ],
              "product_ndc": [
                "0407-0690"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "substance_name": [
                "GADODIAMIDE"
              ],
              "spl_id": [
                "dfe2f58c-7a8f-408a-9690-6300a49eda17"
              ],
              "spl_set_id": [
                "1e9a37e2-f28a-4373-bf0f-3e9b60f42d8a"
              ],
              "package_ndc": [
                "0407-0690-05",
                "0407-0690-10",
                "0407-0690-15",
                "0407-0690-20",
                "0407-0690-12",
                "0407-0690-17",
                "0407-0690-22"
              ],
              "nui": [
                "N0000175862",
                "N0000180184"
              ],
              "pharm_class_moa": [
                "Magnetic Resonance Contrast Activity [MoA]"
              ],
              "pharm_class_epc": [
                "Paramagnetic Contrast Agent [EPC]"
              ],
              "unii": [
                "84F6U3J2R6"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "OMNISCAN",
            "drugauthorizationnumb": "020123",
            "drugdosageform": "SOLUTION FOR INJECTION",
            "drugadministrationroute": "042",
            "drugindication": "HEPATIC MASS",
            "drugstartdateformat": "102",
            "drugstartdate": "20040419",
            "drugenddateformat": "102",
            "drugenddate": "20040419",
            "openfda": {
              "application_number": [
                "NDA020123"
              ],
              "brand_name": [
                "OMNISCAN"
              ],
              "generic_name": [
                "GADODIAMIDE"
              ],
              "manufacturer_name": [
                "GE Healthcare Inc."
              ],
              "product_ndc": [
                "0407-0690"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "substance_name": [
                "GADODIAMIDE"
              ],
              "spl_id": [
                "dfe2f58c-7a8f-408a-9690-6300a49eda17"
              ],
              "spl_set_id": [
                "1e9a37e2-f28a-4373-bf0f-3e9b60f42d8a"
              ],
              "package_ndc": [
                "0407-0690-05",
                "0407-0690-10",
                "0407-0690-15",
                "0407-0690-20",
                "0407-0690-12",
                "0407-0690-17",
                "0407-0690-22"
              ],
              "nui": [
                "N0000175862",
                "N0000180184"
              ],
              "pharm_class_moa": [
                "Magnetic Resonance Contrast Activity [MoA]"
              ],
              "pharm_class_epc": [
                "Paramagnetic Contrast Agent [EPC]"
              ],
              "unii": [
                "84F6U3J2R6"
              ]
            }
          }
        ]
      }
    }
  ]
}